Evidence map›Paper›PMID 32066739›Full record

ArticleTranslational psychiatry2020

Low-frequency parietal repetitive transcranial magnetic stimulation reduces fear and anxiety.

Nicholas L Balderston, Emily M Beydler, Madeline Goodwin, Zhi-De Deng, Thomas Radman, Bruce Luber, Sarah H Lisanby, Monique Ernst, Christian Grillon

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05306977 (Open-label Pilot to Test a Novel 1 Hz Intensive Repetitive Transcranial Magnetic Stimulation Paradigm in Patients With Anxiety), which is not on this map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05306977 naterminatednot on this mapstarted 2022, after this paper: background citation

Open-label Pilot to Test a Novel 1 Hz Intensive Repetitive Transcranial Magnetic Stimulation Paradigm in Patients With Anxiety

TypeinterventionalSponsorUniversity of PennsylvaniaRan2022 to 2022Enrolled5ConditionsGeneralized Anxiety DisorderArmsOpen-label accelerated 1 Hz repetitive transcranial magnetic stimulation
3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Dynamic Tracking of State AnxietyFrontiers in psychiatry · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nicholas L BalderstonSection on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA. nicholas.balderston@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-8565-1544
Emily M BeydlerSection on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Madeline GoodwinSection on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Zhi-De DengNoninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Thomas RadmanNoninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Bruce LuberNoninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Sarah H LisanbyNoninvasive Neuromodulation Unit, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Monique ErnstSection on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
Christian GrillonSection on Neurobiology of Fear and Anxiety, National Institute of Mental Health, National Institutes of Health Bethesda, Bethesda, MD, USA.
National Institutes of Health · US

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
The Psychophysiology Of Fear And AnxietyZIAMH002798 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI GRILLON, CHRISTIAN · 2009 to 2022
$29.0M
Intramural NIH HHS ZIA MH002798U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) ZIAMH002798
6 · The paper itself

Abstract

Anxiety disorders are the most prevalent mental disorders, with few effective neuropharmacological treatments, making treatments development critical. While noninvasive neuromodulation can successfully treat depression, few treatment targets have been identified specifically for anxiety disorders. Previously, we showed that shock threat increases excitability and connectivity of the intraparietal sulcus (IPS). Here we tested the hypothesis that inhibitory repetitive transcranial magnetic stimulation (rTMS) targeting this region would reduce induced anxiety. Subjects were exposed to neutral, predictable, and unpredictable shock threat, while receiving double-blinded, 1 Hz active or sham IPS rTMS. We used global brain connectivity and electric-field modelling to define the single-subject targets. We assessed subjective anxiety with online ratings and physiological arousal with the startle reflex. Startle stimuli (103 dB white noise) probed fear and anxiety during the predictable (fear-potentiated startle, FPS) and unpredictable (anxiety-potentiated startle, APS) conditions. Active rTMS reduced both FPS and APS relative to both the sham and no stimulation conditions. However, the online anxiety ratings showed no difference between the stimulation conditions. These results were not dependent on the laterality of the stimulation, or the subjects' perception of the stimulation (i.e. active vs. sham). Results suggest that reducing IPS excitability during shock threat is sufficient to reduce physiological arousal related to both fear and anxiety, and are consistent with our previous research showing hyperexcitability in this region during threat. By extension, these results suggest that 1 Hz parietal stimulation may be an effective treatment for clinical anxiety, warranting future work in anxiety patients.

Indexed as

FearTranscranial Magnetic StimulationAnxietyAnxiety DisordersHumansReflex, Startle

Identifiers

PMID32066739
PMCPMC7026136
OpenAlexW3005906864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.